PETER R. YOUNG, PH.D. - Corporate Board Profile

CEL SCI CORP

Filing Date	Source Excerpt
2011-02-18	Compensation Committee During the year ending September 30, 2010 CEL-SCI had a Compensation Committee which was comprised of Alexander Esterhazy, Dr. C. Richard Kinsolving and Peter Young. Audit Committee During the year ended September 30, 2010 CEL-SCI had an Audit Committee comprised of Alexander Esterhazy, C. Richard Kinsolving and Peter Young.
2013-05-10	Dr. Peter R. Young 67 Director ... Compensation of Directors During Year Ended September 30, 2012 Peter R. Young $ 44,000 $ - $ 77,496 $ 121,496 ... Audit Committee During the year ended September 30, 2012 CEL-SCI had an Audit Committee comprised of Alexander Esterhazy, C. Richard Kinsolving and Peter Young. ... Compensation Committee CEL-SCI has a compensation committee comprised of Alexander Esterhazy, Dr. C. Richard Kinsolving and Dr. Peter Young, all of whom are independent directors.
2014-05-30	Peter R. Young 69 Director ... CEL-SCI believes Dr. Young's extensive knowledge of the life sciences industry, coupled with his business acumen and financial expertise, gives him the qualifications and skills to serve as a director, the chair of the audit committee, the chair of the nominating committee and a member of CEL-SCI's compensation committee. ... Compensation of Directors During Year Ended September 30, 2013 Peter R. Young $ 44,000 $ - $ 178,112 $ 222,112
2015-04-21	Peter R. Young, Ph.D. (1) 70 Director, Independent Audit, Compensation, and Nominating ... Peter R. Young $ 50,000 -- $ 134,389 $ 184,389
2016-06-09	Peter R. Young, Ph.D. (1) 71 Director, Independent Audit, Compensation, and Nominating ... Compensation of Directors During Year Ended September 30, 2015 Peter R. Young $50,000 - $69,190 $119,190
2017-04-27	Peter R. Young, Ph.D.(1) 71 Director, Independent Audit, Compensation, and Nominating (1) Dr. Young is the chairman of the Audit, Compensation and Nominating committees. Compensation of Directors During Year Ended September 30, 2016 Peter R. Young $ 50,000 - 46,352 $ 96,352
2018-08-08	Name: Peter R. Young, Ph.D., Age: 73, Position: Director, Independent, Committees: Audit, Compensation, and Nominating, Directors’ fees During Year Ended September 30, 2017: Fees $50,000, Option Awards $51,477, Total $101,477.
2019-03-26	Peter R. Young, Ph.D. 74 Director, Independent ... Committees: Audit, Compensation, and Nominating ... Compensation of Directors During Year Ended September 30, 2018 ... Peter R. Young $50,000 Fees, $0 Stock Awards, $152,576 Option Awards, Total $202,576.
2020-03-04	Peter R. Young, Ph.D. has been a Director of CEL-SCI since August 2002. Dr. Young has been a senior executive within the pharmaceutical industry in the United States and Canada for most of his career, originally in organizations that are now part of Sanofi S.A. Over the last 20 years he has primarily held positions of Chief Executive Officer or Chief Financial Officer and has extensive experience with acquisitions and equity financing. Since November 2001, Dr. Young has been the President of Agnus Dei, LLC, which has acted as a partner in an organization managing immune system clinics which treats patients with diseases such as cancer, multiple sclerosis and hepatitis. Dr. Young was also the President and Chief Executive Officer of SRL Technology, Inc., a company involved in the development of pharmaceutical drug delivery systems. Between 1998 and 2001, Dr. Young was the Chief Financial Officer of Adams Laboratories, Inc., the developer of Mucinex®. Dr. Young received his Ph.D. in Organic Chemistry from the University of Bristol, England after obtaining his Bachelor's degree in Honors Chemistry, Mathematics and Economics. Subsequently, he qualified as a Fellow of the Chartered Institute of Management Accountants. CEL-SCI believes Dr. Young’s extensive knowledge of the life sciences industry, coupled with his business acumen and financial expertise, gives him the qualifications and skills to serve as a director, and the chair of CEL-SCI’s audit, nominating and compensation committees.
2021-05-18	Peter R. Young, Ph.D. (1) 76 Director, Independent Audit, Compensation, and Nominating
2022-04-29	Peter R. Young, Ph.D. (1) 77 Director, Independent Audit, Compensation, and Nominating committees
2023-04-10	Peter R. Young, Ph.D. (1) 78 Director, Independent Audit, Compensation, and Nominating committees
2024-03-07	Dr. Young received his Ph.D. in Organic Chemistry from the University of Bristol, England after obtaining his Bachelor's degree in Honors Chemistry, Mathematics and Economics.